XML 82 R58.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-based Compensation (Details)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
Offering_Period
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
Share-based Payment Arrangement, Additional Disclosure [Abstract]      
Proceeds from issuance of common stock | $ $ 87 $ 118 $ 195
Stock Incentive Plans      
Share-based Compensation Arrangement by Share-based Payment Award      
Stock-based compensation cost | $ 218 257 274
Tax benefit | $ (35) (48) (51)
Stock-based compensation cost, net of tax | $ $ 183 $ 209 223
Number of shares reserved for issuance to recipient (in shares) 247.0    
Number of shares available for future grant (in shares) 23.0    
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award      
Expiration from date of award (in years) 10 years    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at beginning of period 25.3    
Granted 2.2    
Forfeited/expired (1.6)    
Outstanding at end of period 25.9 25.3  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Outstanding- weighted average exercise price at beginning of period (in dollars per share) | $ / shares $ 41.58    
Granted | $ / shares 24.59    
Forfeited/expired | $ / shares 37.87    
Outstanding- weighted average price per share end of period (in dollars per share) | $ / shares $ 40.36 $ 41.58  
Weighted Average Remaining Contractual Term (years) 5 years 4 months 24 days    
Aggregate Intrinsic Value | $ $ 0    
Number of shares exercisable at the end of the period 19.7    
Weighted Average Exercise Price per Share, Exercisable at the end of the period | $ / shares $ 44.29    
Weighted Average Remaining Contractual Term (years), Exercisable at the end of the period 4 years 6 months    
Aggregate Intrinsic Value, Exercisable at the end of the Period | $ $ 0    
Intrinsic value of stock options exercised during the period | $ 7 $ 2 25
Share-based Payment Arrangement, Additional Disclosure [Abstract]      
Unrecognized compensation cost, non vested awards at period end | $ $ 20    
Weighted average period unrecognized compensation costs to be recognized (in years) 2 years    
Proceeds from issuance of common stock | $ $ 87 $ 118 $ 195
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected term 5 years 4 months 20 days 5 years 3 months 21 days 5 years 3 months 7 days
Expected volatility 33.00% 31.00% 28.00%
Weighted average grant-date fair value of option | $ / shares $ 5.41 $ 5.91 $ 11.56
Stock Options | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award      
Vesting period 3 years    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected dividend yield 2.25% 1.37% 1.28%
Risk-free interest rate 1.35% 2.27% 1.79%
Stock Options | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected dividend yield 3.88% 2.29% 1.72%
Risk-free interest rate 2.51% 2.84% 2.14%
Exercise of stock options [Member]      
Share-based Payment Arrangement, Additional Disclosure [Abstract]      
Proceeds from issuance of common stock | $ $ 0 $ 6 $ 88
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award      
Number of shares reserved for issuance to recipient (in shares) 74.0    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected volatility 68.00% 34.00% 25.00%
Expected dividend yield 4.89% 3.06% 1.62%
Risk-free interest rate 0.65% 2.20% 1.92%
Weighted average grant-date fair value of option | $ / shares $ 3.18 $ 5.22 $ 8.86
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Shares available for future issuance through the plan 9.0    
Employee Stock Purchase Plan [Abstract]      
Percentage of earnings eligible employees may have withheld under the employee stock purchase plan 10.00%    
Number of offering periods | Offering_Period 4    
Number of months each offering period lasts beginning January 1 and July 1 each year (in months) 3 months    
Percentage of the lower of fair market value of the unit on the commencement date or the fair market value of unit on the last trading day of the offering period 90.00%    
Number of shares sold through the plan (in shares) 65.0    
Restricted Stock And Restricted Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested shares at the beginning of the period 18.1    
Granted 8.2    
Vested (5.4)    
Forfeited (1.9)    
Non vested shares at the end of the period 19.0 18.1  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Weighted Average Grant-Date Fair Value per Share, Non vested shares at the beginning of the period | $ / shares $ 34.72    
Granted | $ / shares 16.53 $ 24.75 $ 47.43
Vested | $ / shares 36.97    
Forfeited | $ / shares 33.66    
Weighted Average Grant-Date Fair Value Per Share, Nonvested shares at the end of the period | $ / shares $ 26.26 $ 34.72  
Total fair value of shares vested during the period | $ $ 79 $ 107 $ 219
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award      
Expiration from date of award (in years) 5 years    
Share-based Payment Arrangement, Additional Disclosure [Abstract]      
Unrecognized compensation cost, non vested awards at period end | $ $ 330    
Weighted average period unrecognized compensation costs to be recognized (in years) 3 years